SCHEMBL1096558

SCHEMBL1096558

Cc1ccc(Oc2ccc(Nc3cc(N)ncn3)cc2C)cn1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 14/20 0.59
EGFR P00533 7/20 0.59
ERBB3 P21860 1/20 0.59
ERBB4 Q15303 1/20 0.59
SCN9A Q15858 2/20 0.50
KCNH2 Q12809 3/20 0.47
SCN5A Q14524 1/20 0.47
TGFBR1 P36897 1/20 0.45
FECH P22830 1/20 0.43
CDK8 P49336 1/20 0.43
MAP2K5 Q13163 1/20 0.43
CDK19 Q9BWU1 1/20 0.43
MKNK2 Q9HBH9 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
MAP4K4 O95819 1/20 0.41
CDK1 P06493 1/20 0.40
CCNB1 P14635 1/20 0.40
CCNA2 P20248 1/20 0.40
CCNE1 P24864 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1095086 0.86 SCN9A (0.47) ERBB2EGFRERBB3ERBB4SCN9A
SCHEMBL2747899 0.80 ERBB2 (0.63) ERBB2EGFRERBB3ERBB4SCN9A
SCHEMBL2748335 0.80 ERBB2 (0.63) ERBB2EGFRERBB3ERBB4SCN9A
Iodide SCHEMBL3900898 0.79 ERBB2 (0.62) ERBB2EGFRERBB3ERBB4SCN9A
SCHEMBL4866251 0.78 EGFR (0.67) ERBB2EGFRERBB3ERBB4KCNH2
SCHEMBL6977010 0.78 ERBB2 (0.57) ERBB2EGFRERBB3ERBB4SCN9A
SCHEMBL5528620 0.77 ERBB2 (0.60) ERBB2EGFRERBB3ERBB4KCNH2
SCHEMBL24167693 0.76 ERBB2 (0.63) ERBB2EGFRERBB3ERBB4KCNH2
SCHEMBL5566581 0.75 ERBB2 (0.69) ERBB2EGFRERBB3ERBB4KCNH2
SCHEMBL20395624 0.75 EGFR (0.66) ERBB2EGFRERBB3ERBB4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153791-B2 substituted pyrimidine compoundssuch as 4-amino-6-(3-chloro-4-fluoro-phenylamino)-pyrimidine-5-carbaldehyde O-methyl oxime, used for treating, preventing or ameliorating a chronic or acute protein kinase mediated diseasea, disorders or conditions JANSSEN PHARMACEUTICA N.V. (BE) 2012-04-10 US disclosed